What should the D9630 chart note include?
Pick your PMS to format the placeholders, then copy.
Drugs/medicaments dispensed for home use. RMH: Medical history reviewed/updates Allergies verified: Allergies/none Indication: Indication/diagnosis Related procedure/diagnosis: Related procedure/diagnosis Medication 1: Medication 1 Drug name: Drug name Strength: Strength Quantity dispensed: Quantity dispensed Directions: Directions Lot number: Lot number Expiration: Expiration Medication 2 (if applicable): Medication 2 if applicable Drug name: Drug name Strength: Strength Quantity dispensed: Quantity dispensed Directions: Directions Patient education: Education/instructions provided Verbal instructions: Given/declined/not applicable Written instructions: Given/declined/not applicable Demonstration: Use/application demonstrated or not applicable Patient understanding: Verbalized understanding/questions Warnings discussed: Side effects, interactions, and precautions reviewed Contact office if symptoms worsen. Patient received medications: Confirmed/notes Adverse reaction/complications: None or describe NV: Next visit
What documentation is required for D9630?
D9630 is a thin code with a tall documentation bar, because the only thing distinguishing it from a written prescription is that the office handled inventory and the patient walked out with the drug. Auditors will look for the inventory chain, the drug identity, and the indication — in that order.
- Indication / clinical reason — the diagnosis or procedure that justifies dispensing today. "Adult moderate-to-high caries risk; xerostomia secondary to polypharmacy" or "Post-SRP infection control" or "Pre-procedure antibiotic prophylaxis per AHA guideline; prosthetic hip joint <2 yr." Generic "preventive" alone is the most common audit weakness.
- Drug name and strength — full proprietary or generic name with concentration (e.g., "PreviDent 5000 Booster — 1.1% sodium fluoride toothpaste," "chlorhexidine gluconate 0.12% oral rinse," "amoxicillin 500 mg capsules"). "Fluoride toothpaste" alone does not support the code; the strength is what makes it Rx-grade.
- Quantity dispensed — "one 3.4 oz / 100 g tube," "one 16 oz bottle," "4 capsules," "one 30-day supply." Quantity ties to the form factor and to anti-diversion documentation for any controlled or antibiotic product.
- Lot number and expiration date — required by FDA-aligned dispensing practice and by most state pharmacy boards when an office dispenses (vs. prescribes). Lot/expiration also protects the office in a future product recall. State boards in CA, TX, NY, FL, WA, OR, and others explicitly require this on dispensed medications; many state OIG audits cite missing lot/expiration as a documentation deficiency.
- Directions for use — exactly what the patient was told to do, in the same language used on the dispensed label. "Brush 1–2 cm of paste on all teeth at bedtime; do not rinse, eat, or drink for 30 minutes; spit excess." or "Rinse 15 mL for 30 seconds twice daily after brushing for 14 days." Match the label.
- Allergy verification — confirm the patient is not allergic to the dispensed agent (or a binder/preservative). Critical for chlorhexidine, amoxicillin, clindamycin, and any patient with reported drug allergies.
- Patient education and warnings — side effects (chlorhexidine staining, fluoride pediatric ingestion warning, antibiotic GI upset, drug interactions), counseling that instructions were both verbal and written, demonstration of use when applicable (tray application, rinse technique), and patient-verbalized understanding.
- Dispensing label — even when state law does not strictly require an Rx-style label on a sample handed to the patient, best practice is to affix or attach a label that includes patient name, drug name and strength, directions, quantity, dispensing dentist, dispensing date, lot, and expiration. Note in the chart that the labeled product was handed to the patient.
- Operator and dispensing dentist — the dentist who authorized the dispense and the staff member who physically handed the product to the patient. Many state boards require dentist signature in the dispensing log even when staff completes the hand-off.
- Patient confirmation of receipt — "patient received product and labeled instructions; verbalized understanding of dosing and warnings." This is the chain-of-custody line that distinguishes D9630 from an Rx that may or may not have been filled.
- Adverse reaction / complications — typically "none observed at time of dispense"; document any in-office swallow, taste objection, or known sensitivity.
- Next visit / follow-up plan — when the patient should return, when the supply should be replenished, and how the office tracks effectiveness (e.g., "reassess caries risk and Rx fluoride at 6-month recall").
- Practice dispensing log entry — separate from the chart, most state pharmacy boards require a dispensing log (paper or electronic) listing patient, drug, lot, expiration, quantity, dispensing date, and dispensing dentist. Note in the chart that the dispense was logged.
For pre-procedure antibiotic prophylaxis specifically, document the underlying medical indication (joint replacement <2 years, prior infective endocarditis, certain congenital cardiac conditions, immunosuppression), the consulting physician's recommendation if obtained, and the timing instruction ("take 2 g amoxicillin PO 60 minutes before tomorrow's appointment"). The 2021 AHA scientific statement and the AAOS/ADA appropriate-use criteria are the standard references.
Why does D9630 get denied?
The most frequent reasons D9630 is denied, downgraded, recouped, or flagged in audit:
- Wrong code for a written prescription — the practice billed D9630 for a drug actually called into a pharmacy. By far the most common error; D9630 is not the "wrote a Rx" code, it is the "handed the patient the product from inventory" code. Carriers spot-check by asking for the dispensing log.
- Missing lot number and expiration — even when the carrier denies the line as non-covered, OIG and state-board audits cite missing lot/expiration as a stand-alone documentation deficiency. Many states require lot and expiration in the chart and in the dispensing log.
- No indication or diagnosis — "fluoride dispensed" with no caries-risk language, no medical reason, no procedure tie-in. Carriers downgrade to patient-pay; auditors flag the chart as cloned.
- Confusion with D9610 / D9612 — the drug was administered in office (an injection of dexamethasone, an antibiotic IM dose, an IV antiviral) and was billed as D9630 instead of the correct parenteral code. D9630 is take-home only.
- Confusion with D1206 / D1208 — fluoride applied in-office was billed as D9630 instead of D1206/D1208. D9630 is the tube the patient took home, not the varnish painted on at the visit.
- Bundled into a global procedure fee — D9630 billed for whitening gel, medicament inside a custom tray included in D5994, or post-op rinse included in a surgical fee. Routine downgrade.
- Missing dispensing log entry — chart has the dispense documented but the practice has no dispensing log. State board audits cite this as a recordkeeping violation independent of the dental claim.
- No directions documented — "fluoride toothpaste dispensed" with no directions for use. Auditors cite this when the chart cannot demonstrate the patient was properly instructed.
- Allergy not verified before dispense — most acute on chlorhexidine and antibiotic dispensing; a documented allergy verification line is the minimum standard.
- OTC product billed as D9630 — a free travel-size toothpaste, sample mints, or non-prescription mouthwash handed at checkout. D9630 is for prescription-strength or clinically indicated medicaments.
- Default-normal autotext / cloned notes — every D9630 dispense charts identically across patients with no indication or product specifics. Carriers and state OIG flag the practice for templating.
- Quantity exceeds reasonable supply — multiple tubes or bottles dispensed at one visit beyond a 30- to 90-day supply, with no rationale. Antibiotic dispensing in particular triggers diversion concerns when quantity is excessive.
- Pre-procedure antibiotic dispense without medical indication on file — the chart documents "amoxicillin 2 g dispensed for prophylaxis" but does not document the joint replacement, infective endocarditis history, or other AHA/AAOS-AUC indication. Audited as inappropriate antibiotic dispensing.
What do practices ask about D9630?
What is the difference between D9630 and writing a prescription?+
D9630 reports a drug physically dispensed from the office's own inventory to the patient for home use — the office pulls a unit, labels it, hands it to the patient, and the patient leaves with the product in hand. A drug prescribed on a paper script or e-Rx and filled at an outside pharmacy is not D9630; there is no separate CDT code for writing a prescription. The dispensing chain (inventory pull, dispensing log, lot, expiration, label) is what justifies the code, and it is the single most common D9630 misuse to bill it for a prescription that was sent to a pharmacy.
What is the difference between D9630 and D9610 / D9612?+
Location of administration. D9610 reports a single in-office parenteral drug administration (an injection or infusion at the chair); D9612 reports two or more different in-office parenterals at one visit. D9630 reports a take-home product handed to the patient. A single appointment can correctly include both — e.g., D9610 for an in-office IM dexamethasone injection and D9630 for a take-home chlorhexidine rinse — but the chart should clearly distinguish which drug supports which code.
Is D9630 covered by insurance?+
Usually not. Most commercial PPO, MetLife FEDVIP, Aetna FEDVIP, Delta Dental, Cigna, BCBS, and Humana plans treat D9630 as a non-covered procedure — the dispensed drug is considered a retail product the patient is responsible for. A few plans assign a token allowance toward dispensed take-home fluoride for high-risk pediatric or post-radiation patients. Pediatric Medicaid coverage is state-specific and limited. Most practices collect the dispensing fee from the patient at the time of dispense and submit the claim to document the chain of custody.
Can D9630 be billed with D1206 or D1208 on the same day?+
Yes, when both events actually occurred. D1206 (or D1208) reports the in-office fluoride application; D9630 reports the take-home prescription-strength fluoride product handed from inventory at the same visit. Each line needs its own indication, product, and quantity. Carriers typically pay the D1206 / D1208 line and deny D9630 as non-covered, which is normal — the patient is billed for the dispensed product directly.
Can D9630 be billed for an antibiotic given for premedication?+
Yes — when the office dispenses the prophylactic dose from its own inventory at a consult or pre-op visit for the patient to take at home one hour before the next appointment. The chart must document the medical indication (prosthetic joint replacement within the appropriate window, prior infective endocarditis, certain congenital cardiac conditions, immunosuppression) consistent with current AHA and AAOS/ADA appropriate-use criteria, the consulting physician's recommendation if obtained, and the timing instruction. If the antibiotic is called into a pharmacy instead, D9630 does not apply.
Do I have to record lot number and expiration date for D9630?+
Yes. Most state pharmacy and dental boards require lot and expiration to be recorded on dispensed products — both in the patient's chart and in the practice's dispensing log. State OIG audits routinely cite missing lot or expiration as a documentation deficiency independent of the dental claim. Lot tracking also protects the practice in any future product recall. Treat lot and expiration the same way you treat anesthetic carpule documentation: nonnegotiable.
Can D9630 be billed for the whitening gel in a take-home whitening case?+
No. Take-home whitening procedures (D9972, D9975, D9974) include the dispensed bleaching product in their global fee. Billing D9630 in addition to the whitening code is a routine downgrade. The same bundling rule applies to medicaments included in a custom medicament carrier (D5994) and to drugs included as part of an in-office desensitization (D9910 / D9911) or fluoride application (D1206 / D1208).